Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD

Open access

Abstract

Objectives: To study the effect of repeated retinal thickness fluctuations during the anti-VEGF therapy maintenance phase in neovascular age-related macular degeneration (nAMD). Methods: Data were extracted from electronic medical records of 381 nAMD patients, aged ≥50 years; baseline VA ≥33 and ≤73 letters; ≥24 months’ follow-up and ≥2 optical coherence tomography (OCT) measurements. OCT scans were analysed using an artificial intelligence algorithm that quantified the volumes of intraretinal fluid (IRF), subretinal fluid (SRF), pigment epithelial detachments (PED) and central subfield thickness (CSFT). IRF, SRF and PED were summed to obtain total fluid (TF). The standard deviation (SD) of IRF, SRF, PED, CSFT and TF was computed and categorised into quartiles (SD-Q). Relationships between SD-Qs for each OCT feature and VA change was tested using generalised estimating equations and linear regression. Results: By Month 24, compared to SD-Q1, eyes in SD-Q2, SD-Q3, and SD-Q4 for IRF, SRF, PED, CSFT and TF showed greater VA losses. Eyes in SD-Q4 of TF were 9.4 letters worse compared to eyes in Q1 (95% Confidence Interval: −12.9 to −6.0). The frequency of clinic visits with IRF and SRF present on OCT scans by quartiles of CSFT was lower in eyes with least fluctuation (Q1) compared to eyes with the most fluid fluctuation (Q4) (median [IQR] IRF: 0.3 [0.0–0.7] versus 0.8 [0.5–1.0]; SRF: 0.0 [0.0–0.5] versus 0.6 [0.3–1.0]). Conclusions: Greater fluctuations in retinal fluid volumes during the maintenance phase of anti-VEGF treatment in nAMD is associated with worse VA by 2 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41433-020-01354-4

Cites

Statistics

Figures

Fig. 1 Representative B scan segmented using the NOA algorithm. The ILM and the hyperreflective RPE band are outlined in green. Two foci of intraretinal fluid are shown delineated in red. Subretinal fluid lying between the RPE band and the outer limits of the photoreceptor layer is seen in orange. ILM, inner limiting membrane; RPE, retinal pigment epithelium.
Fig. 1 Representative B scan segmented using the NOA algorithm. The ILM and the hyperreflective RPE band are outlined in green. Two foci of intraretinal fluid are shown delineated in red. Subretinal fluid lying between the RPE band and the outer limits of the photoreceptor layer is seen in orange. ILM, inner limiting membrane; RPE, retinal pigment epithelium.CC BY · PubMed Central
Fig. 2 GEE models of forest plots of adjusted mean change in VA from Month 3 to Month 24 by SD quartile relative to uartile 1 for each OCT marker of lesion activity. VA changes for Q1 to Q4 for the OCT markers IRF (a), SRF (b), PED (c), CSFT (d), and total fluid (sum of IRF + SRF + PED) (e). The standard deviation for each OCT marker of lesion activity was calculated from all available visits. Point estimates for VA change with 95% CI are shown at Month 24. CI, confidence interval; CSFT, central subfield thickness; GEE, generalised estimating equation; IRF, intraretinal fluid; OCT, optical coherence tomography; PED; pigment epithelial detachment; SD, standard deviation; SRF, subretinal fluid; VA, visual acuity.
Fig. 2 GEE models of forest plots of adjusted mean change in VA from Month 3 to Month 24 by SD quartile relative to uartile 1 for each OCT marker of lesion activity. VA changes for Q1 to Q4 for the OCT markers IRF (a), SRF (b), PED (c), CSFT (d), and total fluid (sum of IRF + SRF + PED) (e). The standard deviation for each OCT marker of lesion activity was calculated from all available visits. Point estimates for VA change with 95% CI are shown at Month 24. CI, confidence interval; CSFT, central subfield thickness; GEE, generalised estimating equation; IRF, intraretinal fluid; OCT, optical coherence tomography; PED; pigment epithelial detachment; SD, standard deviation; SRF, subretinal fluid; VA, visual acuity.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 27 · Cited by 131

Metadata

Authors
Chakravarthy, U., Havilio, M., Syntosi, A., Pillai, N., Wilkes, E., Benyamini, G., Best, C., & Sagkriotis, A.
Affiliations
  • Queen's University Belfast (GB)
  • Notal Vision (Israel) (IL)
  • Novartis (Switzerland) (CH)
  • IQVIA (United Kingdom) (GB)
Corresponding author
Chakravarthy, Usha
Venue
Eye
Published
2021-01-07
Volume
35
Issue
11
Pages
2983-2990
ISSN
  • 0078-5334 (ISSN-L)
  • 0950-222X
  • 1476-5454
OpenAlex
W3119176982
Cited by
131
References
27
Citations by year
2026: 17 · 2025: 29 · 2024: 35 · 2023: 17 · 2022: 20 · 2021: 13
FWCI
19.04
Type
journal article
Language
en
Open access
Licence
Locations
  • Eye (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Novartis (N/A)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
Keywords
neovascular age-related macular degeneration, anti-VEGF therapy, intraretinal fluid, subretinal fluid, pigment epithelial detachment, central subfield thickness, visual acuity loss, optical coherence tomography
MeSH terms
Bevacizumab, Ranibizumab, Artificial Intelligence, Humans, Visual Acuity, Treatment Outcome, Angiogenesis Inhibitors, Tomography, Optical Coherence, Wet Macular Degeneration, Intravitreal Injections, Subretinal Fluid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD. https://app.cochat.ai/papers/10.1038/s41433-020-01354-4
The paper
Chakravarthy, U., Havilio, M., Syntosi, A., Pillai, N., Wilkes, E., Benyamini, G., Best, C., & Sagkriotis, A. (2021). Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD. Eye. https://doi.org/10.1038/s41433-020-01354-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.